Paladin Wealth’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$836K Sell
3,159
-669
-17% -$176K 0.45% 69
2026
Q2
$972K Buy
3,828
+295
+8% +$68.8K 0.57% 58
2026
Q1
$864K Sell
3,533
-477
-12% -$111K 0.59% 54
2025
Q4
$830K Sell
4,010
-1,275
-24% -$252K 0.57% 59
2025
Q3
$980K Sell
5,285
-230
-4% -$39.4K 0.71% 52
2025
Q2
$842K Buy
5,515
+326
+6% +$50.1K 0.66% 59
2025
Q1
$861K Buy
5,189
+192
+4% +$30K 0.77% 52
2024
Q4
$723K Sell
4,997
-350
-7% -$54.2K 0.62% 57
2024
Q3
$867K Buy
+5,347
New +$852K 0.76% 46

Other funds holding JNJ

Paladin Wealth's JNJ Position: Q3 2026 in Review

Paladin Wealth reduced its Johnson & Johnson (JNJ) stake by 17% in Q3 2026, selling an estimated $176K and leaving 3,159 shares worth $836K. The position accounts for 0.45% of the portfolio, ranked #69.

Paladin Wealth first reported a position in JNJ in Q3 2024 and has held it in 9 quarters since. The position peaked at $980K in Q3 2025. 1,735 funds tracked by Wall St. Rank hold JNJ as of Q3 2026.

  • Paladin Wealth held 3,159 shares of Johnson & Johnson worth $836K as of Q3 2026.
  • Paladin Wealth sold 669 Johnson & Johnson shares in Q3 2026, an estimated $176K.
  • Johnson & Johnson made up 0.45% of Paladin Wealth's portfolio in Q3 2026, its #69 holding.
  • Paladin Wealth first reported a position in Johnson & Johnson in Q3 2024 and has held it in 9 quarters since.
  • Paladin Wealth's Johnson & Johnson position peaked at $980K in Q3 2025.
  • 1,735 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2026.

Based on Paladin Wealth's 13F filing for Q3 2026, filed 23 Oct 2026.